Monoclonal antibodies [Monoklonale antikörper]

被引:0
|
作者
Vollmers H.P. [1 ,2 ]
Brändlein S. [1 ]
机构
[1] Pathologisches Institut, Universität Würzburg
[2] Pathologisches Institut, Universität Würzburg, 97080 Würzburg
来源
Der Onkologe | 2005年 / 11卷 / 5期
关键词
Chimerization; HumAb-mouse; Monoclonal antibodies; Phage display; Trioma technique;
D O I
10.1007/s00761-005-0864-y
中图分类号
学科分类号
摘要
Nowadays, monoclonal antibodies are present in all fields of science and medicine and are regarded as a promising addition to conventional therapeutic and diagnostic methods. The success of immunotherapy, however, is crucially dependent on the effectiveness and immunogenicity of the reagents and the specificity of the targeted structures. Since an immunoincompetent organism develops antibodies against foreign proteins, a major goal was to design strategies for chimerization or humanization of murine antibodies. There are currently three experimental approaches for producing human monoclonal antibodies: by phage display, immunization of transgenic mice (HuMAb-Mouse), and classic procedures for somatic hybridization of B cells from patients (trioma technique). © Springer Medizin Verlag 2005.
引用
收藏
页码:494 / 501
页数:7
相关论文
共 50 条
  • [1] Monoklonale Antikörper in der OnkologieImmuntherapienMonoclonal antibodies in oncologyImmunotherapies
    J. Nolting
    D. Wolf
    P. Brossart
    [J]. Forum, 2014, 29 (2) : 112 - 118
  • [2] Monoklonale Antikörper in der Therapie von TumorerkrankungenMonoclonal antibodies in the treatment of malignancy
    M. Kripp
    [J]. Der Onkologe, 2011, 17 (6):
  • [3] Viele monoklonale Antikörper sind nicht monospezifisch
    Dübel S.
    [J]. BIOspektrum, 2018, 24 (4) : 395 - 399
  • [4] New treatment approaches in immunology by monoclonal antibodies [Neue behandlungsansätze in der immunologie durch monoklonale antikörper]
    Rubbert A.
    Diehl V.
    [J]. Der Internist, 2001, 42 (6): : 843 - 853
  • [5] Monoklonale AntikörperMonoclonal antibodies
    J. Mössner
    A. Neubauer
    [J]. Der Internist, 2019, 60 (10): : 1009 - 1013
  • [6] Monoklonale Antikörper: Entwicklung und klinische Perspektiven
    P. Borchmann
    G. Riethmüller
    A. Engert
    [J]. Der Internist, 2001, 42 : 803 - 814
  • [7] Monoklonale Antikörper zur antiinfektiven TherapieMonoclonal antibodies for anti-infective therapy
    Bettina Klug
    Barbara Schnierle
    Isabel Trebesch
    [J]. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2020, 63 : 1396 - 1402
  • [8] Monoklonale Antikörper in der Therapie maligner Lymphome
    C. Buske
    A. Engert
    R. Schnell
    V. Diehl
    W. Hiddemann
    [J]. Der Internist, 1998, 39 : 1205 - 1214
  • [9] Monoklonale Antikörper — Herstellung und VerwendungSpezifische Bindemoleküle
    Katja Heilmann
    Katrin Messerschmidt
    Pamela Holzlöhner
    [J]. BIOspektrum, 2012, 18 (2) : 167 - 169
  • [10] Akute Überempfindlichkeitsreaktionen auf monoklonale Antikörper zur zielgerichteten TherapieAcute hypersensitivity reactions associated with monoclonal antibodies for targeted therapy
    B. Sachs
    H. F. Merk
    [J]. Der Hautarzt, 2018, 69 (4): : 268 - 277